Skip to content

Clinical trials

Waldenstrom Macroglobulinemia trials in Israel

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Waldenstrom Macroglobulinemia Country / region: Israel Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20133
20171
20212
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated4
Active, not recruiting3
Completed2
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC3
AbbVie2
Gilead Sciences2
Cellectar Biosciences, Inc.1
Hutchmed1
Janssen Research & Development, LLC1
Merck Sharp & Dohme LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Waldenstrom Macroglobulinemia11
Leukemia, Lymphocytic, Chronic, B-Cell10
Lymphoma, B-Cell, Marginal Zone9
Lymphoma, Follicular9
Lymphoma, Mantle-Cell8
Lymphoma, Large B-Cell, Diffuse7
Lymphoma, Non-Hodgkin6
Multiple Myeloma4
Recurrence4
Blast Crisis3

Trials

Showing 76 to 11 of 11. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.